Hims & Hers Health Inc Ordinary Shares - Class A HIMS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HIMS is a good fit for your portfolio.
News
-
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
-
Thinking about buying stock in Infobird, PubMatic, Hims & Hers Health, FibroGen, or Alpha Metallurgical Resources?
-
Hims & Hers' stock jumps on hopes of a first profitable year, as it floats opportunities in weight loss
-
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
-
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
-
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
-
WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service
Trading Information
- Previous Close Price
- $15.74
- Day Range
- $15.13–16.16
- 52-Week Range
- $5.65–17.16
- Bid/Ask
- $15.40 / $15.60
- Market Cap
- $3.31 Bil
- Volume/Avg
- 4.3 Mil / 4.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 109.73
- Price/Sales
- 3.71
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.06%
Company Profile
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,046
- Website
- https://www.forhims.com
Comparables
Valuation
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Price/Earnings (Normalized) | 109.73 | — | 23.85 |
Price/Book Value | 9.60 | 0.72 | 3.67 |
Price/Sales | 3.71 | 0.27 | 3.88 |
Price/Cash Flow | 61.50 | — | 18.18 |
Price/Earnings
HIMS
NUTX
GDRX
Financial Strength
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Quick Ratio | 2.56 | 1.21 | 6.79 |
Current Ratio | 3.00 | 1.34 | 7.12 |
Interest Coverage | — | −0.78 | −0.55 |
Quick Ratio
HIMS
NUTX
GDRX
Profitability
Metric
|
HIMS
|
NUTX
|
GDRX
|
---|---|---|---|
Return on Assets (Normalized) | 7.29% | −5.45% | 6.98% |
Return on Equity (Normalized) | 8.97% | −25.02% | 13.70% |
Return on Invested Capital (Normalized) | 8.80% | −2.32% | 8.64% |
Return on Assets
HIMS
NUTX
GDRX
Household & Personal Products Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
PG
| Procter & Gamble Co | Mtdxkpxsy | Wczfd | $381.8 Bil | |
UL
| Unilever PLC ADR | Bmfpbgbl | Bgr | $125.5 Bil | |
CL
| Colgate-Palmolive Co | Mddntmhp | Nbks | $74.0 Bil | |
EL
| The Estee Lauder Companies Inc Class A | Mlghxwvph | Ktxm | $55.3 Bil | |
KMB
| Kimberly-Clark Corp | Bnhmnvtnjt | Kznzv | $43.6 Bil | |
KVUE
| Kenvue Inc | Lddxrftr | Lmv | $41.1 Bil | |
RBGLY
| Reckitt Benckiser Group PLC ADR | Jrgntqb | Byj | $40.3 Bil | |
CHD
| Church & Dwight Co Inc | Nbnnmpd | Dxx | $25.4 Bil | |
CLX
| Clorox Co | Gnyxynqpx | Gslh | $19.0 Bil | |
COTY
| Coty Inc Class A | Hntc | Cyvw | $10.7 Bil |